System offers multiple non-drug therapies for people with chronic pain PARIS, Jan. 31, 2019 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra ...

The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...

Boston Scientific Corp. won a nod from the FDA to market its Spectra Wavewriter spinal cord stimulator (SCS) system to treat pain. The Marlborough, Mass.-based company said its SCS works by sending ...

Boston Scientific Corporation 's BSX successful result from its WHISPER randomized controlled trial (RCT) further boosts its neuromodulation business. This announcement follows the recent FDA approval ...

The FDA gave the green light to Boston Scientific’s first-of-its-kind electric pulse system designed to treat pain without the use of opioids. Dubbed the Spectra WaveWriter, the spinal cord stimulator ...

Boston Scientific Corporation, a world leader of innovative medical device solutions, presented new data demonstrating that the Precision Spectra Spinal Cord Stimulator (SCS) System provided 1.5 times ...

Boston Scientific, Inc. BSX recently received FDA approval for an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (“SCS”) Systems. With this approval, the system will be available ...

DUBLIN, Feb. 10, 2020 /PRNewswire/ -- The "Spinal Cord Stimulators Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. This report covers: Some of the major companies working ...